Dasatinib and the Risk of Pulmonary Arterial Hypertension

Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
In this podcast, Jennifer Shepherd, a pharmacist in the FDA’s Division of Drug Information, discusses the increased risk of pulmonary arterial hypertension associated with Sprycel (dasatinib), a drug indicated to treat leukemia.

To access the podcast, click here.
Related Articles
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses a pharmacist's door-to-door discharge role when managing an ischemic stroke patient.
“Game changers” was the phrase Cedarville University School of Pharmacy Dean Marc Sweeney, PharmD, MDiv, used to describe his students.
A cheery vintage advertisement depicting kids playing in a yard promotes “cocaine toothache drops” sold at an Albany, New York, pharmacy in March 1885.
Pharmacists really do have great profession, and here are 10 reasons why.
Latest Issues
$auto_registration$